Menu

Neurophysiological Correlates of Dissociation Induced by Virtual Reality Hypnosis.

Status

Completed

Conditions

Healthy Volunteers

Treatments

Behavioral: Hypnosis without VR (HYP)
Device: Hypnosis with VR (VRH)

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05357131
QuDDoS - Phase-I

Details and patient eligibility

About

Hypnosis and virtual reality are potential tools in treating acute pain. Nevertheless, the neurophysiological correlates of such tools used together, i.e. 'virtual reality hypnosis' (VRH) (Patterson et al., 2004) remain mostly understudied. This study aims to improve our knowledge and understanding of the dissociation (i.e., a mental separation of components of behaviours that normally would be processed together) occurring during VRH. This is a randomized controlled study that will be conducted on healthy participants. As the final goal is to propose such a tool in the clinical context, a clinical application will also be carried out subsequently.

Thus the principal outcome is to study dissociation in the context of VRH from a behavioral and neurophysiological point of view.

Secondary objectives aim at identifying factors that influence the dissociative effect seen in VRH, as well as measuring traits of hypnotisability, absorption, immersive abilities, dissociation trait and state, pain, and anxiety levels that might impact the effectiveness of such a tool.

Full description

The protocol will follow the following steps:

  1. Before the experiment:

    • A medical screening of the medical history and of any concomitant medications will be performed to eligibility.
    • The 6-item Elkins Hypnotisability Scale (EHS) will be used to assess participant hypnotisability.
    • Questionnaire sur la Propension à l'Immersion (QPI) will be used to assess participant immersion tendency.
  2. Experimental session: Cross-over and within-participant control design i. Visual Analogue Scale (VAS) :

    • Anxiety.
    • Pain. ii. EEG Resting-state (5-Min.). iii. EEG VRH or EEG Hypnosis alone (HYP) (15-Min.). iv. Adverse Events (AE) during the protocol will be recorded. v. Narrative recording. vi. VAS :
    • Dissociation
    • Absorption
    • Pain
    • Anxiety
    • Arousal/wakefulness
    • Automaticity vii. Time perception (open question) viii. CyberSickness (CSQ) (only if VRH) ix. Presence Questionnaire x. Satisfaction questionnaire xi. Washout Phase (30-Min.) during which we will administer :
    • Six-item State-Trait Anxiety Inventory (STAI-6) .
    • Tellegen Absorption Scale .
    • Dissociative Experience Scales (DES) . xii. VAS:
    • Anxiety
    • Pain xiv. Adverse Events during the protocol will be recorded. xv. Narrative recording. xvi. EEG HYP or EEG VRH Phase (15-Min.). xvii. VAS:
    • Dissociation
    • Absorption
    • Pain
    • Anxiety
    • Arousal/wakefulness
    • Time perception xviii. CSQ (only if VRH) xix. Presence Questionnaire. xx. Satisfaction Questionnaire .

Enrollment

68 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Subject more than 18 years old and equal or less than 65 years old.

Exclusion Criteria:

  1. Low auditory and/or visual acuity precludes the use of the device.
  2. Head or face wounds precluding the use of the device.
  3. Schizophrenia, dissociative disorder or any other psychiatric disorder.
  4. Non-proficiency in French (Research language).
  5. Patient under 18 years old.
  6. Phobia of deep water.
  7. Allergy to cutaneous electrodes.
  8. Chronic pain and/or chronic analgesics consumption.
  9. Medication affecting the autonomic nervous system.
  10. Dizziness.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

68 participants in 2 patient groups

Healthy Volunteers - Hypnosis without VR (HYP )
Experimental group
Description:
Cross-over and within-participant control design: Participants will receive recorded hypnosis without VR.
Treatment:
Behavioral: Hypnosis without VR (HYP)
Healthy Volunteers - Hypnosis with VR (VRH)
Experimental group
Description:
Cross-over and within-participant control design: Participants will receive hypnosis with VR.
Treatment:
Device: Hypnosis with VR (VRH)

Trial contacts and locations

1

There are currently no registered sites for this trial.

Central trial contact

Rodrigo Montengro, PhD student; Aminata Bicego, PhD

Timeline

Last updated: Jul 06, 2023

Start date

Jun 08, 2022 • 2 years ago

End date

Jun 14, 2023 • 1 year and 10 months ago

Today

May 03, 2025

Sponsors of this trial

Lead Sponsor

Collaborating Sponsors

Data sourced from clinicaltrials.gov